Crossmark

Characterization of pancreatic NMDA receptors as possible drug targets for diabetes treatment

Crossref DOI link: https://doi.org/10.1038/nm.3822

Published Online: 2015-03-16

Published Print: 2015-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Marquard, Jan

Otter, Silke

Welters, Alena

Stirban, Alin

Fischer, Annelie

Eglinger, Jan https://orcid.org/0000-0001-7234-1435
Herebian, Diran

Kletke, Olaf

Klemen, Maša Skelin

Stožer, Andraž

Wnendt, Stephan

Piemonti, Lorenzo

Köhler, Martin

Ferrer, Jorge https://orcid.org/0000-0002-5959-5729
Thorens, Bernard

Schliess, Freimut

Rupnik, Marjan Slak

Heise, Tim

Berggren, Per-Olof

Klöcker, Nikolaj

Meissner, Thomas

Mayatepek, Ertan

Eberhard, Daniel

Kragl, Martin

Lammert, Eckhard
License Information

Text and Data Mining valid from 2015-03-16
More Information

Article History

Received: 29 October 2014

Accepted: 10 February 2015

First Online: 16 March 2015

Competing interests

: J.M., T.M. and E.L. pursue a patent application (WO 2013/029762 A1) entitled Morphinan-derivatives for treating diabetes and related disorders.